1st Quarter - Report

INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. ____ / S. ____ Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
CARL KIME —
KALI MATALON —
LETITIA WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Government Issues GOV

Contacted Members of Congress to provide information on recent clinical trials, cooperative vaccine research and development agreements with the University of California, and neglected tropical diseases.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
CARL KIME New —
KALI MATALON —
LETITIA WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.